Suppr超能文献

立体定向内置分流术治疗肿瘤相关性非交通性脑积水的微创第三脑室造瘘术。

Minimally invasive third ventriculostomy with stereotactic internal shunt placement for the treatment of tumor-associated noncommunicating hydrocephalus.

机构信息

Department of Neurosurgery, LMU Hospital, Ludwig-Maximilian-University Munich, Marchioninistrasse 15, 81377, Munich, Germany.

出版信息

Acta Neurochir (Wien). 2023 Dec;165(12):4071-4079. doi: 10.1007/s00701-023-05768-3. Epub 2023 Sep 7.

Abstract

BACKGROUND

Intracranial tumors can cause obstructive hydrocephalus (OH). Most often, symptomatic treatment is pursued through ventriculoperitoneal shunt (VS) or endoscopic third ventriculostomy (ETV). In this study, we propose stereotactic third ventriculostomy with internal shunt placement (sTVIP) as an alternative treatment option and assess its safety and efficacy.

METHODS

In this single-center, retrospective analysis, clinical symptoms, procedure-related complications, and revision-free survival of all patients with OH due to tumor formations treated by sTVIP between January 2010 and December 2021 were evaluated.

RESULTS

Clinical records of thirty-eight patients (11 female, 27 male) with a mean age of 40 years (range 5-88) were analyzed. OH was predominantly (in 92% of patients) caused by primary brain tumors (with exception of 3 cases with metastases). Following sTVIP, 74.2% of patients experienced symptomatic improvement. Preoperative headache was a significant predictor of postoperative symptomatic improvement (OR 26.25; 95% CI 4.1-521.1; p = 0.0036). Asymptomatic hemorrhage was detected along the stereotactic trajectory in 2 cases (5.3%). One patient required local revision due to CSF fistula (2.6%); another patient had to undergo secondary surgery to connect the catheter to a valve/abdominal catheter due to CSF malabsorption. However, in the remaining 37 patients, shunt independence was maintained during a median follow-up period of 12 months (IQR 3-32 months). No surgery-related mortality was observed.

CONCLUSIONS

sTVIP led to a significant symptom control and was associated with low operative morbidity, along with a high rate of ventriculoperitoneal shunt independency during the follow-up period. Therefore, sTVIP constitutes a highly effective and minimally invasive treatment option for tumor-associated obstructive hydrocephalus, even in cases with a narrow prepontine interval.

摘要

背景

颅内肿瘤可导致梗阻性脑积水(OH)。通常,通过脑室-腹腔分流术(VS)或内镜第三脑室造瘘术(ETV)进行对症治疗。在本研究中,我们提出立体定向第三脑室造瘘术联合内置分流管(sTVIP)作为一种替代治疗选择,并评估其安全性和疗效。

方法

在这项单中心回顾性分析中,评估了 2010 年 1 月至 2021 年 12 月间所有因肿瘤形成而接受 sTVIP 治疗的 OH 患者的临床症状、与手术相关的并发症以及无翻修生存率。

结果

分析了 38 例患者(11 名女性,27 名男性)的临床记录,平均年龄为 40 岁(范围 5-88 岁)。92%的患者(35 例)OH 由原发性脑肿瘤引起(3 例为转移瘤)。sTVIP 后,74.2%的患者症状得到改善。术前头痛是术后症状改善的显著预测因素(OR 26.25;95%CI 4.1-521.1;p=0.0036)。2 例(5.3%)患者沿立体定向轨迹出现无症状性出血。1 例患者因 CSF 瘘(2.6%)需要局部翻修,另 1 例患者因 CSF 吸收不良需要二次手术将导管连接至阀门/腹部导管。然而,在其余 37 例患者中,在中位随访 12 个月(IQR 3-32 个月)期间维持了分流管独立性。未观察到手术相关死亡。

结论

sTVIP 显著控制了症状,且手术发病率低,在随访期间具有较高的脑室-腹腔分流管独立性。因此,sTVIP 是一种针对肿瘤相关梗阻性脑积水的有效且微创的治疗选择,即使在桥前间隙狭窄的情况下也是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48fc/10739544/22f4aea678a3/701_2023_5768_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验